Why the study?
Does droxidopa improve symptoms and blood pressure in patients with neurogenic orthostatic hypotension?
Does droxidopa improve symptoms and blood pressure in patients with neurogenic orthostatic hypotension?
This review summarizes the pharmacological properties, mechanism of action, and clinical trial results of droxidopa for the treatment of neurogenic orthostatic hypotension.
No takes yet. Share an insight, caveat, or question.
May support short-term use in neurogenic orthostatic hypotension; leaves open long-term efficacy and safety.
Kaufmann et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: